GRANULES - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.8

📈 Analysis: GRANULES presents a moderately strong swing trade setup with bullish technicals and mixed fundamentals. The current price of ₹565 is above both the 50 DMA (₹541) and 200 DMA (₹518), indicating a short-term uptrend. RSI at 57.0 and MACD at 9.37 suggest positive momentum, though volume is below the weekly average. ROCE (10.9%) and ROE (9.14%) are modest, and the PEG ratio of -5.64 signals poor growth valuation. The stock trades at a premium P/E (48.5) compared to the industry average (33.1). Institutional activity is mixed, with FII holdings increasing and DII holdings declining.

🎯 Optimal Entry Price: ₹550–₹560 (on minor pullback near 50 DMA)

🚪 Exit Strategy (if holding): Consider exiting near ₹600–₹615 or if RSI crosses 65 with MACD flattening.

✅ Positive

• 📈 Price above 50 & 200 DMA — bullish technical setup
• 📈 RSI and MACD indicate upward momentum
• 📊 EPS of ₹12.2 — consistent earnings
• 📈 FII holding increased (+0.85%) — foreign investor confidence
• 📉 PAT improved quarter-over-quarter — ₹72.7 Cr. to ₹78.6 Cr.

⚠️ Limitation

• 📉 PEG ratio of -5.64 — poor growth valuation
• 📉 DII holding decreased (-5.61%) — domestic investor caution
• 📉 Volume below weekly average — reduced trading interest
• 📉 Dividend yield of 0.26% — minimal income support
• 📉 Quarterly profit variation of -16.2% — earnings volatility

📰 Company Negative News

• No major public negative news, but valuation and DII reduction are cautionary signals

🌟 Company Positive News

• Quarterly PAT growth and rising FII interest reflect improving sentiment and operational strength

🏭 Industry

• Industry P/E is 33.1 — GRANULES trades at a premium, reflecting investor optimism
• Pharmaceutical sector remains resilient with long-term demand driven by global healthcare needs

🧾 Conclusion

GRANULES is a technically strong swing trade candidate with mixed fundamentals. Entry near support offers a tactical opportunity. Exit near resistance or on RSI/MACD confirmation is advisable.

I can also help you compare GRANULES with peers like Alembic Pharma or Aurobindo Pharma to sharpen your swing strategy.